Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity
Public ClinicalTrials.gov record NCT05956509. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Efficacy, and Tolerability of ABBV-950 for the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients
Study identification
- NCT ID
- NCT05956509
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 1 participant
Conditions and interventions
Conditions
Interventions
- ABBV-950 Biological
- BOTOX Biological
- Placebo for ABBV-950 Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 11, 2024
- Primary completion
- Jun 1, 2024
- Completion
- Jun 1, 2024
- Last update posted
- Jun 30, 2024
2024
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North County Neurology Associates /ID# 256333 | Carlsbad | California | 92011-4213 | — |
| Rancho Los Amigos National Rehabilitation center /ID# 255335 | Downey | California | 90242 | — |
| Neuro Pain Medical Center /ID# 256036 | Fresno | California | 93710-5473 | — |
| New England Institute for Clinical Research /ID# 255020 | Stamford | Connecticut | 06905 | — |
| MedStar National Rehabilitation Hospital /ID# 255630 | Washington D.C. | District of Columbia | 20010 | — |
| JEM Research Institute /ID# 258782 | Lake Worth | Florida | 33462-1141 | — |
| Kansas Institute of Research /ID# 254998 | Overland Park | Kansas | 66211-1363 | — |
| University of Missouri Hospital /ID# 255310 | Columbia | Missouri | 65212 | — |
| Ut Southwestern Medical Center /Parkland Health and Hospital System /Id# 255328 | Dallas | Texas | 75235-7709 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05956509, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 30, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05956509 live on ClinicalTrials.gov.